iBio (IBIO) Intangibles (2011 - 2026)
iBio's (IBIO) quarterly Intangibles came in at $1.8 million in Q1 2026, up 422.86% year-on-year from $350000.0 in Q1 2025, and down 26.89% on a QoQ basis from $2.5 million in Q4 2025.
iBio (IBIO) Intangibles (2011 - 2026) Analysis & Trends
iBio (IBIO) has 16 years of Intangibles data on file, last reported at $1.8 million in Q1 2026.
- On a quarterly basis, Intangibles rose 422.86% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 422.86% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, up 27.57% from the prior year.
- Intangibles for Q1 2026 stood at $1.8 million, down from $2.5 million in the prior quarter.
- Over the last five years, Intangibles for IBIO reached as high as $6.8 million in Q2 2025 and fell as low as $350000.0 in Q1 2025.
- Historically, Intangibles has averaged $3.7 million across 5 years, with a median of $5.0 million in 2023.
- Across the five-year window, Intangibles surged 1166.58% in 2023 and tumbled 92.9% in 2024, its largest moves.
- Year by year, Intangibles stood at $395000.0 in 2022, then jumped by 1166.58% to $5.0 million in 2023, then tumbled by 92.9% to $355000.0 in 2024, then soared by 605.07% to $2.5 million in 2025, then decreased by 26.89% to $1.8 million in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $1.8 million in Q1 2026, $2.5 million in Q4 2025, and $6.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | 11,640.44 |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.58 Bn | 466.79 Bn | 1.35 Bn | 61.68 Mn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.80 Bn | 50.61 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn | - |
| 10 | iBio | 166.24 Mn | 166.24 Mn | - | 1.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.83 Mn |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 6.84 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Mar 31, 2025 | 350,000.00 |
| Dec 31, 2024 | 355,000.00 |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 5.37 Mn |
| Mar 31, 2024 | 370,000.00 |
| Dec 31, 2023 | 5.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 5.39 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 395,000.00 |
| Sep 30, 2022 | 6.01 Mn |
| Jun 30, 2022 | 676,000.00 |
| Mar 31, 2022 | 4.92 Mn |
| Dec 31, 2021 | 5.04 Mn |
| Sep 30, 2021 | 5.16 Mn |
| Jun 30, 2021 | 952,000.00 |